Sweden's I — Tech Q3 net sales rise on higher Selektope adoption
(This story was generated using AI and automation, please see disclaimer ) Overview Sweden biotechnology firm's Q3 net sales rose 19% yr/yr Q3 operating and net profit increased yr/yr Growth driven by higher Selektope adoption and supportive shipping market conditions Outlook Company expects further progress in busines